Literature DB >> 26959108

Metabolic Syndrome and Cognitive Performance Among Chinese ≥50 Years: A Cross-Sectional Study with 3988 Participants.

Baoxin Chen1, Xianglan Jin1, Rongjuan Guo1, Zhigang Chen1, Xiaobing Hou2, Fang Gao1, Yanxia Zhang1, Shuo Zheng1, Chen Fu1, Feiran Xue1, Huanmin Niu1, Yunling Zhang1.   

Abstract

BACKGROUND: To date, the relationship between metabolic syndrome (MetS) and cognitive performance has not been well defined. This study aimed to explore the relationship between MetS and cognitive performance among Chinese elderly population.
METHODS: A cross-sectional study was performed, with data collected in seven clinical centers from five provinces of Northern China. All recruited participants were ≥50 years of age and complained with cognitive impairment or were reported with cognitive impairment by his/her caregiver(s). MetS was diagnosed according to the criteria issued by Chinese Medical Association Diabetes Association. Cognitive function was scored by Montreal Cognitive Assessment (MoCA).
RESULTS: Three thousand nine hundred eighty-eight participants (in an average of 66.4 ± 8.8 years of age, male 53.1%) were included in the analysis. Six hundred seventy-three (16.9%) participants were diagnosed with MetS, and 3013 (75.6%) participants had mild cognitive impairment (MCI) (MoCA score <26). There was no statistically significant difference in the MoCA scores between participants with MetS (21.0 ± 5.4) and without MetS (21.3 ± 5.3). In the logistic regression, after adjusting factors of age, education, marital status, smoking, and physical activity, diabetes and dyslipidemia were associated with MCI, whereas hypertension and overweight or obesity were not. Participants with diabetes had a higher risk of MCI (OR = 1.24, 95% CI: 1.03-1.50). Participants with dyslipidemia had a lower risk of MCI (OR = 0.81, 95% CI: 0.68-0.97).
CONCLUSION: In our study, MetS is not associated with cognitive performance in elderly Chinese population. However, elderly Chinese with diabetes would have lower cognition function, and the dyslipidemia might be reversely associated with the cognitive function.

Entities:  

Mesh:

Year:  2016        PMID: 26959108     DOI: 10.1089/met.2015.0094

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  7 in total

1.  The Predictive Role of Aberrant Metabolic Parameters and Negative Automatic Thinking on the Cognitive Impairments Among Schizophrenia Patients with Metabolic Syndrome.

Authors:  Xueying Zhang; Chen He; Peijun Ju; Wen Xie; Cuizhen Zhu; Qingrong Xia; Jianliang Gao; Loufeng Zhang; Xuequan Chen; Hui Yuan; Hua Gao; Yang Zhang; Junwei Yan
Journal:  Neuropsychiatr Dis Treat       Date:  2022-06-07       Impact factor: 2.989

2.  High BMI levels associate with reduced mRNA expression of IL10 and increased mRNA expression of iNOS (NOS2) in human frontal cortex.

Authors:  J K Lauridsen; R H Olesen; J Vendelbo; T M Hyde; J E Kleinman; B M Bibby; B Brock; J Rungby; A Larsen
Journal:  Transl Psychiatry       Date:  2017-02-28       Impact factor: 6.222

3.  Associations of the metabolic syndrome and its components with cognitive impairment in older adults.

Authors:  Insa Feinkohl; Jürgen Janke; Daniel Hadzidiakos; Arjen Slooter; Georg Winterer; Claudia Spies; Tobias Pischon
Journal:  BMC Geriatr       Date:  2019-03-07       Impact factor: 3.921

4.  The association of metabolic syndrome and cognitive impairment in Jidong of China: a cross-sectional study.

Authors:  Xiaohui Wang; Long Ji; Zhaoyang Tang; Guoyong Ding; Xueyu Chen; Jian Lv; Yanru Chen; Dong Li
Journal:  BMC Endocr Disord       Date:  2021-03-04       Impact factor: 2.763

5.  Estimation of losses of quality-adjusted life expectancy attributed to the combination of cognitive impairment and multimorbidity among Chinese adults aged 45 years and older.

Authors:  Suting Xiong; Siyuan Liu; Yanan Qiao; Dingliu He; Chaofu Ke; Yueping Shen
Journal:  BMC Public Health       Date:  2021-01-05       Impact factor: 3.295

6.  The Association Between the Duration, Treatment, Control of Hypertension and Lifestyle Risk Factors in Middle-Aged and Elderly Patients with Mild Cognitive Impairment: A Case-Control Study.

Authors:  Xiwu Yan; Ting Meng; Huaijun Liu; Jinfeng Liu; Juan Du; Cheng Chang
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-19       Impact factor: 2.570

7.  Association of obesity, diabetes and hypertension with cognitive impairment in older age.

Authors:  Insa Feinkohl; Gunnar Lachmann; Tobias Pischon; Claudia Spies; Wolf-Rüdiger Brockhaus; Friedrich Borchers; Sophie K Piper; Thomas H Ottens; Hendrik M Nathoe; Anne-Mette Sauer; Jan M Dieleman; Finn M Radtke; Diederik van Dijk
Journal:  Clin Epidemiol       Date:  2018-07-25       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.